Page last updated: 2024-08-26

uftoral and Invasiveness, Neoplasm

uftoral has been researched along with Invasiveness, Neoplasm in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hwang, SH; Kim, SG1
Aoki, H; Aoki, N; Hayashi, S; Hemmi, A; Karube, H; Masuda, H; Nakayama, H; Ogame, H; Sakamoto, N; Wakabayashi, K1
Inada, K; Ishikawa, T; Kamoshida, S; Maeda, K; Matsuoka, H; Shimomura, R; Tsutsumi, Y1
Shoji, Y; Toyooka, M1
Hioki, M; Hirano, S; Hirata, T; Hisayoshi, T; Kutsukata, N; Masuda, S; Yamagishi, S; Yamamoto, S; Yamashita, Y1
Choi, S; Habelhah, H; Hosokawa, M; Kobayashi, M; Konishi, Y; Nakae, D; Okada, F; Totsuka, Y1

Other Studies

6 other study(ies) available for uftoral and Invasiveness, Neoplasm

ArticleYear
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
    World journal of surgical oncology, 2016, Apr-02, Volume: 14

    Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Floxuridine; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Oxonic Acid; Prognosis; Retrospective Studies; Stomach Neoplasms; Survival Rate; Tegafur; Time Factors; Uracil

2016
[A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2004, Volume: 31, Issue:2

    Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Lentinan; Middle Aged; Neoplasm Invasiveness; Peritoneal Neoplasms; Peritoneum; Stomach Neoplasms; Survivors; Tegafur; Uracil

2004
Immunohistochemical evaluation of thymidylate synthase (TS) and p16INK4a in advanced colorectal cancer: implication of TS expression in 5-FU-based adjuvant chemotherapy.
    Japanese journal of clinical oncology, 2004, Volume: 34, Issue:10

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Chemotherapy, Adjuvant; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p16; Drug Combinations; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Neoplasm Invasiveness; Postoperative Period; Rectal Neoplasms; Tegafur; Thymidylate Synthase; Uracil

2004
[A case of effective regimen of tegafur and uracil (UFT)/leucovorin (LV) plus irinotecan (CPT-11) for advanced rectal carcinoma with severe pelvic infiltration to be performed curative resection].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:4

    Topics: Adenocarcinoma; Administration, Oral; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Humans; Irinotecan; Leucovorin; Male; Neoadjuvant Therapy; Neoplasm Invasiveness; Pelvic Neoplasms; Quality of Life; Rectal Neoplasms; Tegafur; Uracil

2007
[A case of far-advanced gastric cancer treated with neoadjuvant combination chemotherapy of UFT, low-dose CDDP and leucovorin, followed by subtotal gastrectomy with curative intent].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1997, Volume: 24, Issue:9

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Drug Administration Schedule; Drug Combinations; Gastrectomy; Humans; Leucovorin; Male; Neoplasm Invasiveness; Portal Vein; Stomach Neoplasms; Tegafur; Uracil

1997
Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.
    Anti-cancer drugs, 1999, Volume: 10, Issue:2

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Chemotaxis; Cisplatin; Clone Cells; Drug Combinations; Drug Resistance, Neoplasm; Female; Fibrosarcoma; Inhibitory Concentration 50; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; RNA, Messenger; RNA, Neoplasm; Tegafur; Tissue Inhibitor of Metalloproteinase-1; Tumor Cells, Cultured; Uracil

1999